-
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – PEEL-224 in Solid Tumor
Overview How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. PEEL-224 in Solid Tumor Drug Details: PEEL-224 is under development for the treatment of...
-
Product Insights
New![]()
Frodsham Wind Farm
Frodsham Wind Farm is an Onshore Wind project located in England, United Kingdom. The project is owned by Foresight Group LLP; Peel NRE Developments Ltd and was developed by Belltown Power Ltd; Peel NRE Developments Ltd. The project came online in 2017. Empower your strategies with our Frodsham Wind Farm report and make more profitable business decisions. Note: This is an on-demand report that will be delivered upon request. The report will be delivered within 2 to 3 business day...
-
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – Lifirafenib Maleate in Bile Duct Cancer (Cholangiocarcinoma)
How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData's proprietary machine learning algorithms developed using over 10 years of historical data. Lifirafenib Maleate in Bile Duct Cancer (Cholangiocarcinoma) Drug Details: Lifirafenib maleate is under development for...
-
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – QRX-003 in Netherton Syndrome (Trichorrhexis Invaginata, Bamboo Hair)
OverviewHow likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData's proprietary machine learning algorithms developed using over 10 years of historical data.QRX-003 in Netherton Syndrome (Trichorrhexis Invaginata, Bamboo Hair)Drug Details:QRX-003 is under development for the treatment of...
-
Product Insights
New![]()
Ince Bio-power Plant
Ince Bio-power Plant is a biopower project located in England, United Kingdom. The project is owned by Bioenergy Infrastructure Group; Peel NRE Limited and was developed by CoGen Ltd. The project came online in 2018. Empower your strategies with our Ince Bio-power Plant report and make more profitable business decisions. Note: This is an on-demand report that will be delivered upon request. The report will be delivered within 2 to 3 business day of the purchase, excluding weekends and holidays....
-
Product Insights
New![]()
Beaw Field Wind Farm
Beaw Field Wind Farm is an Onshore Wind project located in Scotland, United Kingdom. The project is owned by Statkraft UK Ltd and is developed by Enertrag AG; Peel NRE Developments Ltd; Statkraft UK Ltd. The project is at the permitting stage. Empower your strategies with our Beaw Field Wind Farm report and make more profitable business decisions. Note: This is an on-demand report that will be delivered upon request. The report will be delivered within 2 to 3 business...
-
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – Obexelimab in Immunoglobulin G4-Related Disease (IgG4-RD)
How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData's proprietary machine learning algorithms developed using over 10 years of historical data. Obexelimab in Immunoglobulin G4-Related Disease (IgG4-RD) Drug Details: Obexelimab (XmAb-5871) is under development for the...
-
Product Insights
![]()
Peel Region – Peel Manor Seniors Service Hub – Ontario
Equip yourself with the essential tools needed to make informed and profitable decisions with our Peel Region - Peel Manor Seniors Service Hub - Ontario report./b> Note: This is an on-demand report that will be delivered upon request. The report will be delivered within 2 business days of the purchase, excluding weekends and holidays. Certain sections of the report may be removed or altered based on data availability and relevance. Why choose our report? Unleash the full story: Dive deep...
-
Product Insights
![]()
Peel Land – Peel L&P Waters Residential Community – Manchester
Equip yourself with the essential tools needed to make informed and profitable decisions with our Peel Land - Peel L&P Waters Residential Community - Manchester report./b> Note: This is an on-demand report that will be delivered upon request. The report will be delivered within 2 business days of the purchase, excluding weekends and holidays. Certain sections of the report may be removed or altered based on data availability and relevance. Why choose our report? Unleash the full story: Dive deep...
-
Product Insights
![]()
Peel Environmental/ Peel L&P – North Clyde Plastic-to-Hydrogen Plant – West Dunbartonshire
Equip yourself with the essential tools needed to make informed and profitable decisions with our Peel Environmental/ Peel L&P - North Clyde Plastic-to-Hydrogen Plant - West Dunbartonshire report./b> Note: This is an on-demand report that will be delivered upon request. The report will be delivered within 2 business days of the purchase, excluding weekends and holidays. Certain sections of the report may be removed or altered based on data availability and relevance. Why choose our report? Unleash the full story:...
Sign up to receive regular alerts for our latest analysis and reports. No matter your industry focus, you can keep your finger on the pulse with our timely updates.